[Federal Register Volume 75, Number 129 (Wednesday, July 7, 2010)]
[Notices]
[Page 39028]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2010-16387]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Clinical Laboratory Improvement Advisory Committee (CLIAC)
In accordance with section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92-463), the Centers for Disease Control and
Prevention (CDC) announces the following meeting of the aforementioned
committee:
Times and Dates:
8:30 a.m.-5 p.m., September 1, 2010.
8:30 a.m.-3 p.m., September 2, 2010.
Place: CDC, 1600 Clifton Road, NE., Tom Harkin Global
Communications Center, Building 19, Room 232, Auditorium B, Atlanta,
Georgia 30333.
Online Registration Required: In order to expedite the security
clearance process at the CDC Roybal Campus located on Clifton Road,
all CLIAC attendees are required to register for the meeting online
at least 14 days in advance at http://wwwn.cdc.gov/cliac/default.aspx by clicking the ``Register for a Meeting'' link and
completing all forms according to the instructions given. Please
complete all the required fields before submitting your registration
and submit no later than August 17, 2010.
Status: Open to the public, limited only by the space available.
The meeting room accommodates approximately 100 people.
Purpose: This Committee is charged with providing scientific and
technical advice and guidance to the Secretary of Health and Human
Services, the Assistant Secretary for Health, and the Director, CDC,
regarding the need for, and the nature of, revisions to the
standards under which clinical laboratories are regulated; the
impact on medical and laboratory practice of proposed revisions to
the standards; and the modification of the standards to accommodate
technological advances.
Matters to be Discussed: The agenda will include agency updates
from the CDC, the Centers for Medicare & Medicaid Services, and the
Food and Drug Administration. Reports and Committee discussion will
address issues pertaining to cytology testing and workload
recording; the electronic exchange of laboratory information; and
consideration of proposals from the CLIAC proficiency testing
workgroup. Agenda items are subject to change as priorities dictate.
Providing Oral or Written Comments: It is the policy of CLIAC to
accept written public comments and provide a brief period for oral
public comments whenever possible.
Oral Comments: In general, each individual or group requesting
to make an oral presentation will be limited to a total time of five
minutes (unless otherwise indicated). Speakers must also submit
their comments in writing for inclusion in the meeting's Summary
Report. To assure adequate time is scheduled for public comments,
individuals or groups planning to make an oral presentation should,
when possible, notify the contact person below at least one week
prior to the meeting date.
Written Comments: For individuals or groups unable to attend the
meeting, CLIAC accepts written comments until the date of the
meeting (unless otherwise stated). However, the comments should be
received at least one week prior to the meeting date so that the
comments may be made available to the Committee for their
consideration and public distribution. Written comments, one hard
copy with original signature, should be provided to the contact
person below. Written comments will be included in the meeting's
Summary Report.
Contact Person for Additional Information: Nancy Anderson,
Chief, Laboratory Practice Standards Branch, Division of Laboratory
Science and Standards (proposed), Laboratory Science, Policy and
Practice Program Office (LSPPPO) (proposed), Office of Surveillance,
Epidemiology and Laboratory Services (proposed), Centers for Disease
Control and Prevention, 1600 Clifton Road, NE., Mailstop F-11,
Atlanta, Georgia 30333; telephone (404) 498-2741; fax (404) 498-
2219; or via e-mail at [email protected].
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register Notices pertaining
to announcements of meetings and other committee management
activities, for CDC and the Agency for Toxic Substances and Disease
Registry.
Dated: June 28, 2010.
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease
Control and Prevention.
[FR Doc. 2010-16387 Filed 7-6-10; 8:45 am]
BILLING CODE 4163-18-P